Since the onset of the coronavirus pandemic, some companies have been trying to do their part in helping the world get back to some sense of normalcy. As scientists speculate on the possibility COVID-19 becomes another recurring disease humans learn to live with, much like the flu, delivery giant UPS says it's committed to the continued safe distribution of vaccines around the world.
"The world is now vaccinating roughly six million people a day. That'll be 5.4 years before we get to 75 percent of the world's population," Scott Price, head of international operations for UPS, told Cheddar.
"What I can tell you is that given the size and the scope of the world's population and in our network, we're always going to be prepared for the capacity needs to get this vaccine around the world," he added.
The company's services aren't just limited to the needs of the United States. While the AstraZeneca vaccine has not been cleared for use in the U.S., UPS has worked closely with other countries, South Korea in particular, in distribution efforts. Price said the company is willing to transport any vaccine to any place in need.
UPS Healthcare and the UPS Foundation have also donated $3 million to COVID vaccination efforts.
"Distribution is really critical when it comes to vaccines. We've been doing healthcare distribution. We have a pretty substantial segment, but you know the ultra-low temperature required on these vaccines is what makes this one particularly unique," Price said. "Now, we have cold storage capability, so as part of our donation, that $3 million, part of it is just capacity of that ultra-low temperature."
With the company delivering nearly 25 million packages every day, Price said UPS has "plenty of capacity" to ensure the safe delivery of vaccines worldwide.
"We have to continue to drive solutions in manufacturing so that we're able to get these into the arms of citizens around the world," he explained.
Federal health officials are expanding an investigation into potentially lead-tainted pouches of apple cinnamon fruit puree marketed for children amid reports of more illnesses and additional product recalls.
Berkshire Hathaway, the conglomerate run by businessman Warren Buffett, reported its operating earnings in its most recent quarter jumped more than 40% from a year ago but posted its first net quarterly loss in a year.
Maks Chmerkovskiy and wife Peta Murgatroyd, of "Dancing With the Stars" fame, are branching out into skincare.
Donald Trump began testifying Monday morning in his civil fraud trial, producing the spectacle of a former president and the leading Republican presidential candidate defending himself against allegations that he dramatically inflated his net worth.
The trial between Google and the maker of the game Fortnite will begin Monday as a San Francisco jury will hear Epic Games' case claiming the Google Play Store takes an unfair commission on purchases made through apps.
One of the most self-made and success stories in the country, Emma Grede, has worked along with the Kardashian Jenner family on many of their best-known brands. Grede, CEO and co-founder of Good American, gave back to the next generation of business leaders as a featured speaker at the Chase for Business Make Your Move summit last week. She spoke with Cheddar News about her career, her company's fashion brand, working with the famous Kardashian-Jennifer family and balancing her own family life.
Berkshire Hathaway, the conglomerate run by businessman Warren Buffett, reported its operating earnings in its most recent quarter jumped more than 40% from a year ago but posted its first net quarterly loss in a year.
Elon Musk's company XaI has announced a new chatbot called Grok.
SAG-AFTRA said over the weekend that it received the studios' last best and final offer following a meeting on Saturday, with the union saying it's reviewing it and considering a response "within the context of the critical issues addressed in our proposals."
Stocks rose slightly as Wall Street looks to continue its momentum with earnings season winding down.
